Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 22
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Beta-blocker treatment of patients with atrial fibrillation attenuates spontaneous calcium release-induced electrical activity

  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Llach, Anna|||0000-0002-7486-1079
  • Gich, Ignasi|||0000-0003-3975-6588
  • Casellas Casanovas, Sandra|||0009-0000-5558-3125
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Chen, S.R. Wayne
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Ginel, Antonino|||0000-0002-8820-7545
  • Benítez, Raúl|||0000-0002-8782-9406
  • Cinca, Juan|||0000-0003-4819-4265
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Madsen, Leif Hove|||0000-0001-5493-3998
Aims: Atrial fibrillation (AF) has been associated with excessive spontaneous calcium release, linked to cyclic AMP (cAMP)-dependent phosphorylation of calcium regulatory proteins. Because β-blockers are expected to attenuate cAMP-dependent signaling, we aimed to examine whether the treatment of patients with β-blockers affected the incidence of spontaneous calcium release events or transient inward currents (I). Methods: The impact of treatment with commonly used β-blockers was analyzed in human atrial myocytes from 371 patients using patch-clamp technique, confocal calcium imaging or immunofluorescent labeling. Data were analyzed using multivariate regression analysis taking into account potentially confounding effects of relevant clinical factors Results: The L-type calcium current (I) density was diminished significantly in patients with chronic but not paroxysmal AF and the treatment of patients with β-blockers did not affect I density in any group. By contrast, the I frequency was elevated in patients with either paroxysmal or chronic AF that did not receive treatment, and β-blocker treatment reduced the frequency to levels observed in patients without AF. Confocal calcium imaging showed that β-blocker treatment also reduced the calcium spark frequency in patients with AF to levels observed in those without AF. Furthermore, phosphorylation of the ryanodine receptor (RyR2) at Ser-2808 and phospholamban at Ser-16 was significantly lower in patients with AF that received β-blockers. Conclusion: Together, our findings demonstrate that β-blocker treatment may be of therapeutic utility to prevent spontaneous calcium release-induced atrial electrical activity; especially in patients with a history of paroxysmal AF displaying preserved I density.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Electrophysiological and histological characterization of atrial scarring in a model of isolated atrial myocardial infarction

  • Amorós Figueras, Gerard|||0000-0002-2109-5550
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Company-Se, Georgina|||0000-0002-0473-4955
  • Arzamendi, Dabit|||0000-0001-7543-5867
  • Jorge, Esther|||0000-0002-2777-0000
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Macías, Y.
  • Sanchez-Quintana, Damian
  • Rosell Ferrer, Javier|||0000-0002-9691-328X
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Cinca, Juan|||0000-0003-4819-4265
Characterization of atrial myocardial infarction is hampered by the frequent concurrence of ventricular infarction. Theoretically, atrial infarct scarring could be recognized by multifrequency tissue impedance, like in ventricular infarction, but this remains to be proven. Objective: This study aimed at developing a model of atrial infarction to assess the potential of multifrequency impedance to recognize areas of atrial infarct scar. Seven anesthetized pigs were submitted to transcatheter occlusion of atrial coronary branches arising from the left coronary circumflex artery. Six weeks later the animals were anesthetized and underwent atrial voltage mapping and multifrequency impedance recordings. The hearts were thereafter extracted for anatomopathological study. Two additional pigs not submitted to atrial branch occlusion were used as controls. Selective occlusion of the atrial branches induced areas of healed infarction in the left atrium in 6 of the 7 cases. Endocardial mapping of the left atrium showed reduced multi-frequency impedance (Phase angle at 307 kHz: from -17.1° ± 5.0° to -8.9° ± 2.6°, p <.01) and low-voltage of bipolar electrograms (.2 ± 0.1 mV vs. 1.9 ± 1.5 mV vs., p <.01) in areas affected by the infarction. Data variability of the impedance phase angle was lower than that of bipolar voltage (coefficient of variability of phase angle at307 kHz vs. bipolar voltage:.30 vs.77). Histological analysis excluded the presence of ventricular infarction. Selective occlusion of atrial coronary branches permits to set up a model of selective atrial infarction. Atrial multifrequency impedance mapping allowed recognition of atrial infarct scarring with lesser data variability than local bipolar voltage mapping. Our model may have potential applicability on the study of atrial arrhythmia mechanisms.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients

  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Martínez, Andrea
  • García Rodríguez, Jesús Eduardo|||0000-0002-7758-6789
  • Dandurand, Jany
  • Polishchuk, Anna
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • Cenarro, Ana
  • Civeira, Fernando|||0000-0001-7043-0952
  • Bernabé, Amable
  • Viladés Medel, David|||0000-0002-3638-9703
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Samouillan, Valerie|||0000-0003-0571-3985
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Patients with familial hypercholesterolemia (FH) exhibit a significant residual cardiovascular risk. A new cardiovascular risk factor is the susceptibility of individual LDL particles to aggregation. This study examined LDL aggregation and its relationship with LDL lipid composition and biophysical properties in patients with FH compared to controls. LDL aggregation was measured as the change in particle size, assessed by dynamic light scattering, after exposure to sphingomyelinase, which breaks down sphingomyelin in the LDL phospholipid layer. Dynamic light scattering and transmission electron microscopy showed that LDL in FH patients exhibited smaller size and greater susceptibility to aggregation. Biochemical analyses revealed a higher cholesteryl ester (CE)/ApoB100 ratio in LDL from FH patients. Differential scanning calorimetry showed that LDL from FH patients had higher transition temperatures, indicating a more ordered CE core. Fourier transform infrared spectroscopy revealed fewer flexible α-helices (1658 cm⁻ 1) and more stable α-helices (1651 cm⁻ 1) in ApoB100 of LDL from FH patients. These structural changes correlated with higher CE content and increased LDL aggregation. In conclusion, a more ordered CE core in smaller LDL particles, combined with a higher proportion of stable α-helices in ApoB100, promotes LDL aggregation in FH patients. These findings suggest ApoB100 conformational structure as a new potential therapeutic targets within LDL to reduce cardiovascular risk in FH patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Guideline-directed medical therapy after revascularization and outcomes in ischaemic cardiomyopathy

  • Moliner-Abós, Carles|||0000-0002-9264-5804
  • Calvo-Barceló, Maria
  • Solé González, Eduard|||0000-0002-5727-9925
  • Borrellas Martín, Andrea
  • Fluvià Brugués, Paula
  • Sánchez Vega, Jesus
  • Vime Jubany, Joan
  • Ferré Vallverdú, Maria
  • Tauron, Manel|||0000-0002-5864-519X
  • Tobias Castillo, Pablo Eduardo
  • de la Fuente Mancera, Juan Carlos
  • Vilardell Rigau, Pau
  • Vila Olives, Rosa
  • Diez López, Carles
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Arzamendi, Dabit|||0000-0001-7543-5867
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Mirabet Pérez, Sonia|||0000-0001-5955-2748
Guideline-directed medical therapy (GDMT) remains the cornerstone for treating patients with heart failure (HF) and reduced ejection fraction (HFrEF) and coronary artery disease (CAD). However, real-world implementation of GDMT (GDMTi) is suboptimal. This subanalysis of the RevascHeart study evaluates the impact of GDMTi on long-term mortality in patients with de novo ischaemic heart failure (HF) undergoing revascularization. Among 409 patients with HFrEF (left ventricular ejection fraction ≤40%) and CAD, 275 one-year survivors who underwent revascularisation shortly after index HF admission were included in this landmark analysis (LA). GDMTi at 12 months was defined as initiation of each recommended drug class, regardless of dose. Primary endpoints were all-cause and cardiovascular mortality by GDMTi. Secondary endpoints included outcomes by revascularisation strategy and temporal trends in GDMTi. Over a median follow-up of 41.6 months, all-cause mortality occurred in 29 GDMTi patients (18%) versus 47 non-GDMTi (42%) and cardiovascular mortality in 10% versus 24%, respectively. After adjustment, GDMTi was not significantly associated with lower all-cause [hazard ratio (HR) 0.63, 95% confidence interval (CI) 0.39-1.02; P = 0.06] or cardiovascular mortality (HR 0.62, 95% CI 0.33-1.18; P = 0.14). GDMTi/coronary artery bypass grafting (CABG) was associated with lower all-cause (HR 0.42, 95% CI 0.20-0.87; P = 0.02) and cardiovascular mortality (HR 0.40, 95% CI 0.16-0.99; P = 0.05). GDMTi use increased progressively over the study period. GDMTi was associated with lower unadjusted mortality, though not significant after adjustment. GDMTi combined with CABG showed the best outcomes. The use of GDMTi improved over time.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission, The RevascHeart study

  • Moliner-Abós, Carles|||0000-0002-9264-5804
  • Calvo-Barceló, Maria
  • Solé González, Eduard|||0000-0002-5727-9925
  • Borrellas Martín, Andrea
  • Fluvià Brugués, Paula
  • Sánchez Vega, Jesús|||0000-0001-7250-8362
  • Tauron, Manel|||0000-0002-5864-519X
  • Tobías-Castillo, Pablo E.|||0000-0003-0304-6197
  • de la Fuente Mancera, Juan Carlos
  • Vilardell Rigau, Pau
  • Vila-Olives, Rosa|||0000-0002-2933-2020
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Arzamendi, Dabit|||0000-0001-7543-5867
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Mirabet Pérez, Sonia|||0000-0001-5955-2748
Aims: Despite numerous trials on revascularization in patients with heart failure (HF) and ischaemic left ventricular (LV) dysfunction, its role remains unsettled. Guideline-directed medical therapy (GDMT) for HF has shown benefits on outcomes. This multicentre study aims to compare long-term mortality between revascularization and GDMT in patients with ischaemic LV dysfunction following admission for HF. Methods and results: Between 2012 and 2023, 408 patients admitted for HF with a LV ejection fraction (LVEF) of 40% or less and documented coronary artery disease (CAD) were included. Patients were categorized into two groups based on their initial treatment decision: revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG]) or GDMT. The primary outcome was rate of all-cause or cardiovascular mortality, and secondary outcomes included type of revascularization (PCI vs. CABG) and LV reverse remodelling. After a median 44.6-month follow-up, 100 patients (33%) died in the revascularization group, compared to 44 (43%) in the GDMT group. Multivariate analysis showed no significant benefit of revascularization on all-cause mortality (hazard ratio [HR] 0.81, 95% confidence interval [CI] 0.48-1.39, p = 0.45) or cardiovascular mortality (HR 0.97, 95% CI 0.62-1.52, p = 0.90) compared to GDMT. Neither CABG (HR 0.74, 95% CI 0.51-1.08, p = 0.13) nor PCI (HR 0.98, 95% CI 0.62-1.55, p = 0.93) demonstrated a mortality reduction compared to GDMT. Both groups experienced significant reductions in LV size and improvements in LVEF, greater in the revascularization group. Conclusion: Revascularization did not outperform GDMT in ischaemic LV dysfunction following HF admission in this retrospective analysis. Larger prospective studies are needed to clarify the potential role of revascularization in improving outcomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characterization of hepatic, portal, and renal venous flow patterns by Doppler ultrasound across tricuspid regurgitation grades Caracterización de los patrones de flujo venoso hepático, portal y renal mediante ecografía Doppler según los grados de insuficiencia tricuspídea, Caracterización de los patrones de flujo venoso hepático, portal y renal mediante ecografía Doppler según los grados de insuficiencia tricuspídea

  • Rodríguez-Pérez, Álvaro|||0000-0003-0037-3440
  • Moliner Abós, Carlos|||0000-0002-9264-5804
  • Viladés Medel, David|||0000-0002-3638-9703
  • Fernández Martínez, Juan|||0000-0002-2011-2136
  • Mayol Domingo, josep
  • Ruiz-López, Adrià
  • Salido, Mario|||0000-0002-7898-2329
  • Descalzo, Martin|||0000-0003-3736-7191
  • Pujadas, Sandra|||0000-0001-5232-4865
  • Menduiña, Irene|||0000-0002-9061-0755
  • Bos-Real, L.|||0000-0002-6159-0644
  • Parada Barcia, José A|||0000-0003-1817-9697
  • Barreiro-Pérez, Manuel|||0000-0001-7489-2935
  • Forado Benatar, Ilana|||0000-0002-3871-8451
  • Arenas Loriente, Andrea|||0000-0002-5313-2379
  • Leta, Rubén|||0000-0003-4691-381X
  • Arzamendi, Dabit|||0000-0001-7543-5867
  • Li, Chi Hion|||0000-0001-7556-3711
Introduction and objectives: Hepatic, portal, and intrarenal venous flows are impaired in significant tricuspid regurgitation (TR), but the impact of massive and torrential TR remains unclear. This study assessed these venous flow patterns across the 5-grade TR classification and their potential as grading markers. Methods: Patients with TR were prospectively included from 3 centers. Exclusion criteria were admission for heart failure, cirrhosis, and stage V renal disease. TR severity was classified using biplane vena contracta width and 2-dimensional effective regurgitant orifice area. Venous flow patterns (hepatic vein reverse systolic flow, portal pulsatility fraction, monophasic intrarenal flow, and reverse portal and intrarenal systolic flows) were analyzed for each TR grade. Results: Of the 143 patients (52 grade III, 30 grade IV, 17 grade V TR), worsening TR was associated with progressively abnormal venous flow. Hepatic vein reverse flow had high sensitivity (96%) but lower specificity (73%) for grade III TR and was less useful for grades IV-V. Monophasic intrarenal flow had high specificity (97%) for grade III TR. Portal pulsatility fraction worsened with severity, with cutoffs of ≥ 40% for grade III, ≥ 80% for grade IV, and > 100% for grade V. Reverse portal and intrarenal systolic flows were highly specific for grade V (94% and 97%, respectively). Conclusions: Increasing TR severity correlates with abnormal hepatic, portal, and intrarenal venous flow patterns, which can be assessed through routine echocardiography., Introducción y objetivos: Los flujos venosos hepático, portal e intrarrenal se alteran en la insuficiencia tricuspídea (IT) significativa, pero el impacto de la IT masiva y torrencial no está claro. Este estudio evaluó estos patrones de flujo en los 5 grados de la clasificación de IT y su utilidad como marcadores de gradación. ́ Métodos: Se incluyó prospectivamente a pacientes con IT en 3 centros. Se excluyó a aquellos con ingreso por insuficiencia cardiaca, cirrosis o enfermedad renal estadio V. La gravedad de la IT se clasificó mediante la anchura de la vena contracta biplanar y el área del orificio regurgitante efectiva en 2 dimensiones. Se analizaron los patrones de flujo venoso (flujo sistólico reverso en vena hepática, fracción de pulsatilidad portal, flujo intrarrenal monofásico y flujos sistólicos reversos portal e intrarrenal) según cada grado de IT. Resultados: En 143 pacientes (52 de grado III, 30 de grado IV y 17 de grado V), la IT más grave se asoció a mayores alteraciones del flujo venoso. El flujo reverso en vena hepática tuvo alta sensibilidad (96%), pero menor especificidad (73%) para IT de grado III, y fue menos útil en grados más avanzados. El flujo intrarrenal monofásico mostró una alta especificidad (97%) para la IT de grado III. La fraccioń de pulsatilidad portal aumentó con la gravedad: ≥ 40% en el grado III, ≥ 80% en el grado IV y > 100% en el grado V. Los flujos sistólicos reversos portal e intrarrenal fueron altamente específicos para el grado V (el 94 y el 97%, respectivamente). Conclusiones: La progresión de la IT se asocia con alteraciones progresivas en los flujos venosos hepático, portal e intrarrenal, evaluables mediante ecocardiografía rutinaria.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

VEXUS and Hepatorenal Congestion Improvements After Transcatheter Tricuspid Intervention: Clinical and Prognostic Insights

  • Rodríguez-Pérez, Álvaro|||0000-0003-0037-3440
  • Li, Chi-Hion Pedro
  • Forado Benatar, Ilana|||0000-0002-3871-8451
  • Guzman Bofarull, Joan
  • Arenas Loriente, Andrea|||0000-0002-5313-2379
  • Asmarats, Lluís|||0000-0002-3357-5834
  • Moliner-Abós, Carles|||0000-0002-9264-5804
  • Fernández Martínez, Juan|||0000-0002-2011-2136
  • Viladés Medel, David|||0000-0002-3638-9703
  • Ruiz-López, Adrià
  • Santaló-Corcoy, Marcel|||0000-0001-7925-7789
  • Maestro, Alba|||0000-0003-1785-3125
  • Menduiña, Irene|||0000-0002-9061-0755
  • Zegrí-Reiriz, Isabel|||0000-0001-9742-8537
  • Mirabet Pérez, Sonia|||0000-0001-5955-2748
  • Parada Barcia, José A|||0000-0003-1817-9697
  • Barreiro-Pérez, Manuel|||0000-0001-7489-2935
  • Estevez-Loureiro, Rodrigo|||0000-0001-5841-5514
  • Freixa, Xavier|||0000-0002-3203-9060
  • Morr, Carlos Igor
  • Sanchis, Laura|||0000-0003-2516-8953
  • Abdul-Jawad Altisent, Omar|||0000-0002-8884-0172
  • Sitges, Marta|||0000-0003-1300-4732
  • Farrero, Marta|||0000-0002-2404-8821
  • Arzamendi, Dabit|||0000-0001-7543-5867
Transcatheter tricuspid valve intervention (TTVI) improves venous congestion, yet the prognostic role of venous Doppler ultrasound remains unclear. In this prospective multicenter cohort (n=64), hepatic, portal, and intrarenal venous flow were assessed before and 24 hours after TTVI and during 1-year follow-up. Venous congestion improved rapidly, with 66% of patients reclassified to VEXUS ≤1 despite no change in diuretic therapy, and these improvements persisted over time. Persistent post-procedural VEXUS grade 3 was independently associated with increased mortality (HR 5.55; 95% CI 1.60–19.21; p=0.007). Early venous ultrasound assessment may help identify residual risk following TTVI.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prevalence and prognostic impact of subclinical pulmonary congestion at discharge in patients with acute heart failure

  • Rivas-Lasarte, Mercedes|||0000-0002-8704-3104
  • Maestro, Alba|||0000-0003-1785-3125
  • Fernández Martínez, Juan|||0000-0002-2011-2136
  • López López, Laura|||0000-0002-8653-6206
  • Solé González, Eduard|||0000-0002-5727-9925
  • Vives-Borrás, Miquel|||0000-0002-5345-4124
  • Montero, Santiago|||0000-0002-0984-3472
  • Mesado, Nuria
  • Pirla, Maria José
  • Mirabet Pérez, Sonia|||0000-0001-5955-2748
  • Fluvià, Paula|||0000-0002-4683-9122
  • Brossa Loidi, Vicens|||0000-0003-0403-6425
  • Sionis, Alessandro|||0000-0003-0843-9512
  • Roig, Eulàlia|||0000-0002-3421-4985
  • Cinca, Juan|||0000-0003-4819-4265
  • Alvarez-Garcia, Jesus|||0000-0002-2015-6446
Residual pulmonary congestion at hospital discharge can worsen the outcomes in patients with heart failure (HF) and can be detected by lung ultrasound (LUS). The aim of this study was to analyse the prevalence of subclinical pulmonary congestion at discharge and its impact on prognosis in patients admitted for acute HF. This is a post-hoc analysis of the LUS-HF trial. LUS was performed by the investigators in eight chest zones with a pocket device. Physical exam was subsequently performed by the treating physicians. Primary outcome was a combined endpoint of rehospitalization, unexpected visit for HF worsening or death at 6- month follow-up. Subclinical pulmonary congestion at discharge was defined as the presence of ≥5 B-lines in LUS in absence of rales in the auscultation employing the area under the ROC curve. At discharge, 100 patients (81%) did not show clinical signs of pulmonary congestion. Of these, 41 had ≥5 B-lines. Independent factors related with the presence of subclinical pulmonary congestion were anaemia, higher New York Heart Association (NYHA) class, and N terminal pro brain natriuretic peptide (NT-proBNP). After adjusting by propensity score analysis including age, renal insufficiency, atrial fibrillation, NYHA class, NT-proBNP levels, clinical congestion, and the trial intervention, the presence of subclinical pulmonary congestion at discharge was a risk factor for the occurrence of the primary outcome (hazard ratio 2.63; 95% confidence interval: 1.08-6.41; P = 0.033). Up to 40% of patients considered 'dry' according to pulmonary auscultation presents subclinical congestion at hospital discharge that can be detected by LUS and implies a worse prognosis at 6- month follow-up. Comorbidities, high values of natriuretic peptides, and higher NYHA class are the factors related with its presence.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Changes in Local Atrial Electrograms and Surface ECG Induced by Acute Atrial Myocardial Infarction

  • Amorós Figueras, Gerard|||0000-0002-2109-5550
  • Roselló-Díez, Elena|||0000-0003-2258-3246
  • Sanchez-Quintana, Damian
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Jorge, Esther|||0000-0002-2777-0000
  • Nevado-Medina, Jorge
  • Arzamendi, Dabit|||0000-0001-7543-5867
  • Millán, Xavier|||0000-0001-6519-4190
  • Alonso-Martin, Concepción|||0000-0001-8041-0445
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Cinca, Juan|||0000-0003-4819-4265
Atrial coronary branch occlusion is a hardly recognizable clinical entity that can promote atrial fibrillation. The low diagnostic accuracy of the ECG could deal with the characteristics of the ischemia-induced changes in local atrial electrograms, but these have not been described. We analyzed the effects of selective acute atrial branch occlusion on local myocardial structure, atrial electrograms, and surface ECG in an experimental model close to human cardiac anatomy and electrophysiology. Six anesthetized open-chest anesthetized pigs underwent surgical occlusion of an atrial coronary branch arising from the right coronary artery during 4 h. Atrial electrograms and ECG were simultaneously recorded. One additional pig acted as sham control. In all cases, the hearts were processed for anatomopathological analysis. Atrial branch occlusion induced patchy atrial necrosis with sharp border zone. During the first 30 min of occlusion, atrial electrograms showed progressive R wave enlargement (1.8 ± 0.6 mV vs. 2.5 ± 1.1 mV, p < 0.01), delayed local activation times (28.5 ± 8.9 ms vs. 36.1 ± 16.4 ms, p < 0.01), ST segment elevation (-0.3 ± 0.3 mV vs. 1.0 ± 1.0 mV, p < 0.01), and presence of monophasic potentials. Atrial ST segment elevation decreased after 2 h of occlusion. The electrical border zone was ∼1 mm and expanded over time. After 2 h of occlusion, the ECG showed a decrease in P wave amplitude (from 0.09 ± 0.04 mV to 0.05 ± 0.04 mV after 165 min occlusion, p < 0.05) and duration (64.4 ± 8.0 ms vs. 80.9 ± 12.6 ms, p < 0.01). Selective atrial branch occlusion induces patchy atrial infarction and characteristic changes in atrial activation, R/S wave, and ST segment that are not discernible at the ECG. Only indirect changes in P wave amplitude and duration were appreciated in advanced stages of acute coronary occlusion.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Plasma microRNA Profiling Reveals Novel Biomarkers of Epicardial Adipose Tissue, A Multidetector Computed Tomography Study

  • Gonzalo Calvo, David de|||0000-0003-2240-3532
  • Viladés Medel, David|||0000-0002-3638-9703
  • Martínez-Camblor, Pablo|||0000-0001-7845-3905
  • Vea Badenes, Angela|||0000-0001-7856-6635
  • Ferrero-Gregori, Andreu|||0000-0001-6492-2416
  • Nasarre, Laura
  • Bornachea, Olga
  • Sánchez Vega, Jesús|||0000-0001-7250-8362
  • Leta, Rubén|||0000-0003-4691-381X
  • Puig Grifol, Núria|||0000-0002-4699-3162
  • Benitez, Sonia|||0000-0003-3565-0743
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Carreras Costa, Francesc|||0000-0002-1944-0562
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Epicardial adipose tissue (EAT) constitutes a novel parameter for cardiometabolic risk assessment and a target for therapy. Here, we evaluated for the first time the plasma microRNA (miRNA) profile as a source of biomarkers for epicardial fat volume (EFV). miRNAs were profiled in plasma samples from 180 patients whose EFV was quantified using multidetector computed tomography. In the screening study, 54 deregulated miRNAs were identified in patients with high EFV levels (highest tertile) compared with matched patients with low EFV levels (lowest tertile). After filtering, 12 miRNAs were selected for subsequent validation. In the validation study, miR-15b-3p, miR-22-3p, miR-148a-3p miR-148b-3p and miR-590-5p were directly associated with EFV, even after adjustment for confounding factors (p value < 0.05 for all models). The addition of miRNA combinations to a model based on clinical variables improved the discrimination (area under the receiver-operating-characteristic curve (AUC) from 0.721 to 0.787). miRNAs correctly reclassified a significant proportion of patients with an integrated discrimination improvement (IDI) index of 0.101 and a net reclassification improvement (NRI) index of 0.650. Decision tree models used miRNA combinations to improve their classification accuracy. These results were reproduced using two proposed clinical cutoffs for epicardial fat burden. Internal validation corroborated the robustness of the models. In conclusion, plasma miRNAs constitute novel biomarkers of epicardial fat burden.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction, A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries)

  • Viladés Medel, David|||0000-0002-3638-9703
  • Degano, Irene R.|||0000-0003-1914-6934
  • Subirana, Isaac|||0000-0003-1676-0197
  • Descalzo, Martin|||0000-0003-3736-7191
  • Padilla-Lopez, Mireia|||0000-0002-4374-3870
  • Mundet-Tudurí, Xavier|||0000-0002-0318-8657
  • Carreras Costa, Francesc|||0000-0002-1944-0562
  • Alomar Serrallach, Xavier
  • Camps-Vilaró, Anna|||0000-0001-9644-8421
  • Elosua, Roberto|||0000-0001-8235-0095
  • Marrugat, Jaume|||0000-0003-3320-554X
  • Leta, Rubén|||0000-0003-4691-381X
Accurate identification of individuals at high coronary risk would reduce acute coronary syndrome incidence and morbi-mortality. We analyzed the effect on coronary risk prediction of adding coronary artery calcification (CAC) and Segment Involvement Score (SIS) to cardiovascular risk factors. This was a prospective cohort study of asymptomatic patients recruited between 2013-2017. All participants underwent a coronary computed tomography angiography to determine CAC and SIS. The cohort was followed-up for a composite endpoint of myocardial infarction, coronary angiography and/or revascularization (median = five years). Discrimination and reclassification of the REGICOR function with CAC/SIS were examined with the Sommer's D index and with the Net reclassification index (NRI). Nine of the 251 individuals included had an event. Of the included participants, 94 had a CAC = 0 and 85 a SIS = 0, none of them had an event. The addition of SIS or of SIS and CAC to the REGICOR risk function significantly increased the discrimination capacity from 0.74 to 0.89. Reclassification improved significantly when SIS or both scores were included. CAC and SIS were associated with five-year coronary event incidence, independently of cardiovascular risk factors. Discrimination and reclassification of the REGICOR risk function were significantly improved by both indexes, but SIS overrode the effect of CAC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of sex on intracellular calcium homoeostasis in patients with atrial fibrillation

  • Herraiz-Martínez, Adela
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Llach, Anna|||0000-0002-7486-1079
  • Godoy-Marín, Hector|||0000-0002-1534-6309
  • Colino-Lage, Hildegard|||0000-0002-8290-6070
  • Nolla-Colomer, Carme|||0000-0002-7681-3556
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Izquierdo-Castro, Paloma|||0000-0003-1494-5665
  • Benitez, Ivan David|||0000-0002-3558-5948
  • Benítez, Raúl|||0000-0002-8782-9406
  • Roselló-Díez, Elena|||0000-0003-2258-3246
  • Rodríguez-Font, Enrique|||0000-0001-5895-4219
  • Viñolas, Xavier|||0000-0002-8243-1271
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Cinca, Juan|||0000-0003-4819-4265
  • Madsen, Leif Hove|||0000-0001-5493-3998
Atrial fibrillation (AF) has been associated with intracellular calcium disturbances in human atrial myocytes, but little is known about the potential influence of sex and we here aimed to address this issue. Alterations in calcium regulatory mechanisms were assessed in human atrial myocytes from patients without AF or with long-standing persistent or permanent AF. Patch-clamp measurements revealed that L-type calcium current (I ) density was significantly smaller in males with than without AF (-1.15 ± 0.37 vs. -2.06 ± 0.29 pA/pF) but not in females with AF (-1.88 ± 0.40 vs. -2.21 ± 0.0.30 pA/pF). In contrast, transient inward currents (I ) were more frequent in females with than without AF (1.92 ± 0.36 vs. 1.10 ± 0.19 events/min) but not in males with AF. Moreover, confocal calcium imaging showed that females with AF had more calcium spark sites than those without AF (9.8 ± 1.8 vs. 2.2 ± 1.9 sites/µm 2) and sparks were wider (3.0 ± 0.3 vs. 2.2 ± 0.3 µm) and lasted longer (79 ± 6 vs. 55 ± 8 ms), favouring their fusion into calcium waves that triggers I s and afterdepolarizations. This was linked to higher ryanodine receptor phosphorylation at s2808 in women with AF, and inhibition of adenosine A or beta-adrenergic receptors that modulate s2808 phosphorylation was able to reduce the higher incidence of I in women with AF. Perturbations of the calcium homoeostasis in AF is sex-dependent, concurring with increased spontaneous SR calcium release-induced electrical activity in women but not in men, and with diminished I density in men only. This work was supported by grants from The Spanish Ministry of Science Innovation and Universities [.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Apolipoprotein and lrp1-based peptides as new therapeutic tools in atherosclerosis

  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • Solanelles Curco, Angels
  • García Rodríguez, Jesús Eduardo|||0000-0002-7758-6789
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Rives Jimenez, Jose|||0009-0001-5725-9270
  • Benitez, Sonia|||0000-0003-3565-0743
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Apolipoprotein (Apo)-based mimetic peptides have been shown to reduce atherosclerosis. Most of the ApoC-II and ApoE mimetics exert anti-atherosclerotic effects by improving lipid profile. ApoC-II mimetics reverse hypertriglyceridemia and ApoE-based peptides such as Ac-hE18A-NH2 reduce cholesterol and triglyceride (TG) levels in humans. Conversely, other classes of ApoE and ApoA-I mimetic peptides and, more recently, ApoJ and LRP1-based peptides, exhibit several antiatherosclerotic actions in experimental models without influencing lipoprotein profile. These other mimetic peptides display at least one atheroprotective mechanism such as providing LDL stability against mechanical modification or conferring protection against the action of lipolytic enzymes inducing LDL aggregation in the arterial intima. Other anti-atherosclerotic effects exerted by these peptides also include protection against foam cell formation and inflammation, and induction of reverse cholesterol transport. Although the underlying mechanisms of action are still poorly described, the recent findings suggest that these mimetics could confer atheroprotection by favorably influencing lipoprotein function rather than lipoprotein levels. Despite the promising results obtained with peptide mimetics, the assessment of their stability, atheroprotective efficacy and tissue targeted delivery are issues currently under progress.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes

  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Casellas Casanovas, Sandra|||0009-0000-5558-3125
  • Lu, Tien Tina
  • Izquierdo-Castro, Paloma|||0000-0003-1494-5665
  • Gich, Ignasi|||0000-0003-3975-6588
  • Jiménez Farrerons, Marcel|||0000-0002-6602-7332
  • Ginel, Antonino|||0000-0002-8820-7545
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Chen, S.R.Wayne
  • Benítez, Raúl|||0000-0002-8782-9406
  • Madsen, Leif Hove|||0000-0001-5493-3998
A hallmark of atrial fibrillation is an excess of spontaneous calcium release events, which can be mimicked by β1- or β2-adrenergic stimulation. Because β1-adrenergic receptor blockers (β1-blockers) are primarily used in clinical practice, we here examined the impact of β2-adrenergic stimulation on spontaneous calcium release and assessed whether the R- and S-enantiomers of the non-selective β- blocker carvedilol could reverse these effects. For this purpose, human atrial myocytes were isolated from patients undergoing cardiovascular surgery and subjected to confocal calcium imaging or immunofluorescent labeling of the ryanodine receptor (RyR2). Interestingly, the β2-adrenergic agonist fenoterol increased the incidence of calcium sparks and waves to levels observed with the non-specific β-adrenergic agonist isoproterenol. Moreover, fenoterol increased both the amplitude and duration of the sparks, facilitating their fusion into calcium waves. Subsequent application of the non β-blocking R-Carvedilol enantiomer reversed these effects of fenoterol in a dose-dependent manner. R-Carvedilol also reversed the fenoterol-induced phosphorylation of the RyR2 at Ser-2808 dose-dependently, and 1 µM of either R- or S-Carvedilol fully reversed the effect of fenoterol. Together, these findings demonstrate that β2-adrenergic stimulation alone stimulates RyR2 phosphorylation at Ser-2808 and spontaneous calcium release maximally, and points to carvedilol as a tool to attenuate the pathological activation of β2-receptors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells

  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • Martínez Bosch, Neus|||0000-0003-3596-0039
  • Manero-Rupérez, Noemí
  • Claudi, Lene
  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Soler Castany, Marta
  • Ros-Blanco, Lia
  • Navarro, Pilar|||0000-0003-4314-4584
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Dyslipidemia, metabolic disorders and/or obesity are postulated as risk factors for pancreatic ductal adenocarcinoma (PDAC). The majority of patients with these metabolic alterations have low density lipoproteins (LDLs) with increased susceptibility to become aggregated in the extracellular matrix (ECM). LDL aggregation can be efficiently inhibited by low-density lipoprotein receptor-related protein 1 (LRP1)-based peptides. The objectives of this work were: (i) to determine if aggregated LDLs affect the intracellular cholesteryl ester (CE)/free cholesterol (FC) ratio and/or the tumor pancreatic cell proliferation, using sphingomyelinase-modified LDL particles (Aggregated LDL, AgLDL); and (ii) to test whether LRP1-based peptides, highly efficient against LDL aggregation, can interfere in these processes. For this, we exposed human pancreatic cancer cell lines (PANC-1, RWP-1 and Capan-1) to native (nLDL) or AgLDLs in the absence or presence of LRP1-based peptides (DP3) or irrelevant peptides (IP321). Results of thin-layer chromatography (TLC) following lipid extraction indicate that AgLDLs induce a higher intracellular CE/FC ratio than nLDL, and that DP3 but not IP321 counteracts this effect. AgLDLs also increase PANC-1 cell proliferation, which is inhibited by the DP3 peptide. Our results indicate that AgLDL-induced intracellular CE accumulation plays a crucial role in the proliferation of pancreatic tumor cell lines. Peptides with anti-LDL aggregation properties may thus exhibit anti-tumor effects.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18 F-FDG PET in patients with a recent ischemic stroke

  • García Rodríguez, Jesús Eduardo|||0000-0002-7758-6789
  • Camps-Renom, Pol|||0000-0001-6587-6271
  • Puig Calvó, Núria|||0000-0001-8235-4934
  • Fernández León, Alejandro|||0000-0002-1010-9451
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • Solé, Arnau|||0009-0007-6517-6188
  • Viladés Medel, David|||0000-0002-3638-9703
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Jiménez Xarrié, Elena|||0000-0003-3567-0672
  • Benitez, Sonia|||0000-0003-3565-0743
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
18 F-fluorodeoxyglucose positron emission tomography (18 F-FDG PET) identifies carotid plaque inflammation and predicts stroke recurrence. Our aim was to evaluate the performance of soluble low-density lipoprotein receptor-related protein 1 (sLRP1) as an indicator of carotid plaque inflammation. A prospective study was conducted among adult patients with recent (< 7 days) anterior circulation ischemic stroke and at least one atherosclerotic plaque in the ipsilateral internal carotid artery. Patients underwent an early (< 15 days from inclusion) 18 F-FDG PET, and the maximum standardized uptake value (SUVmax) within the plaque was measured. sLRP1 levels were measured in plasma samples by ELISA. The association of sLRP1 with SUVmax was assessed using bivariate and multivariable linear regression analyses. Hazard ratios (HR) were estimated with Cox regression to evaluate the association between circulating sLRP1 and stroke recurrence. The study was conducted with 64 participants, of which 57.8% had ≥ 50% carotid stenosis. The multivariable linear and logistic regression analyses showed that sLRP1 was independently associated with (i) SUVmax within the plaque (β = 0.159, 95% CI 0.062-0.257, p = 0.002) and (ii) a probability of presenting SUVmax ≥ 2.85 g/mL (OR = 1.31, 95% CI 1.00-1.01, p = 0.046), respectively. Participants with stroke recurrence showed higher sLRP1 levels at baseline [6447 ng/mL (4897-11163) vs. 3713 ng/mL (2793-4730); p = 0.018]. sLRP1 was independently associated with carotid plaque inflammation as measured by 18 F-FDG PET in patients with recent ischemic stroke and carotid atherosclerosis. The online version contains supplementary material available at 10.1186/s12967-022-03867-w.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

β2-adrenergic stimulation potentiates spontaneous calcium release by increasing signal mass and co-activation of ryanodine receptor clusters

  • Nolla-Colomer, Carme|||0000-0002-7681-3556
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Vallmitjana, Alexander
  • Tarifa, Carmen|||0000-0001-8954-6058
  • Herraiz-Martínez, Adela
  • Llach, Anna|||0000-0002-7486-1079
  • Tauron, Manel|||0000-0002-5864-519X
  • Montiel, José|||0000-0002-3791-5218
  • Cinca, Juan|||0000-0003-4819-4265
  • Chen, S.R.W.|||0000-0001-5808-0304
  • Benitez, R.
  • Madsen, Leif Hove|||0000-0001-5493-3998
Aims: It is unknown how β-adrenergic stimulation affects calcium dynamics in individual RyR2 clusters and leads to the induction of spontaneous calcium waves. To address this, we analysed spontaneous calcium release events in green fluorescent protein (GFP)-tagged RyR2 clusters. Methods: Cardiomyocytes from mice with GFP-tagged RyR2 or human right atrial tissue were subjected to immunofluorescent labelling or confocal calcium imaging. Results: Spontaneous calcium release from single RyR2 clusters induced 91.4% ± 2.0% of all calcium sparks while 8.0% ± 1.6% were caused by release from two neighbouring clusters. Sparks with two RyR2 clusters had 40% bigger amplitude, were 26% wider, and lasted 35% longer at half maximum. Consequently, the spark mass was larger in two- than one-cluster sparks with a median and interquartile range for the cumulative distribution of 15.7 ± 20.1 vs 7.6 ± 5.7 a.u. (P <.01). β2-adrenergic stimulation increased RyR2 phosphorylation at s2809 and s2815, tripled the fraction of two- and three-cluster sparks, and significantly increased the spark mass. Interestingly, the amplitude and mass of the calcium released from a RyR2 cluster were proportional to the SR calcium load, but the firing rate was not. The spark mass was also higher in 33 patients with atrial fibrillation than in 36 without (22.9 ± 23.4 a.u. vs 10.7 ± 10.9; P =.015). Conclusions: Most sparks are caused by activation of a single RyR2 cluster at baseline while β-adrenergic stimulation doubles the mass and the number of clusters per spark. This mimics the shift in the cumulative spark mass distribution observed in myocytes from patients with atrial fibrillation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control

  • García, Eduardo
  • Gil, Pedro|||0000-0003-3707-7450
  • Miñambres, Inka|||0000-0002-0899-3938
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • Rodríguez, Claudia
  • Claudi, Lene
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Benitez, Sonia|||0000-0003-3565-0743
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Rives Jimenez, Jose|||0009-0001-5725-9270
  • Garcia-Moll, Xavier|||0000-0001-7837-8378
  • Viladés Medel, David|||0000-0002-3638-9703
  • Pérez, Antonio|||0000-0001-5528-1143
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
Low-density lipoprotein receptor-related protein 1 (LRP1) negatively modulates circulating atrial natriuretic peptide (ANP) levels. Both molecules are involved in the regulation of cardiometabolism. To evaluate soluble LRP1 (sLRP1) and ANP levels in people with newly diagnosed type 2 diabetes mellitus (T2DM) and determine the effects of metabolic optimization. This single-center longitudinal observational study recruited patients with newly diagnosed T2DM (n = 29, HbA1c.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia

  • Samouillan, Valerie|||0000-0003-0571-3985
  • García Rodríguez, Jesús Eduardo|||0000-0002-7758-6789
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Dandurand, Jany
  • Actis Dato, Virginia|||0000-0002-9071-8045
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Chiabrando, Gustavo
  • Enrich, Carlos|||0000-0003-0382-2993
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
The accumulation of lipids in cardiomyocytes contributes to cardiac dysfunction. The specific blockage of cardiomyocyte cholesteryl ester (CE) loading by antibodies (Abs) against the P3 sequence (Gly 1127 -Cys 1140) of the LRP1 receptor improves cardiac insulin sensitivity. The impact of anti-P3 Abs on high-fat diet (HFD)-induced cardiac extracellular matrix (ECM) biophysical alterations was analyzed. Both IrP (without Abs) and P3-immunized rabbits (with Abs) were randomized into groups fed either HFD or a standard chow diet. Cardiac lipids, proteins, and carbohydrates were characterized by Fourier transform infrared spectroscopy in the attenuated total reflectance mode. The hydric organization and physical structure were determined by differential scanning calorimetry. HFD increased the levels of esterified lipids, collagen, and α-helical structures and upregulated fibrosis, bound water, and ECM plasticization in the heart. The inhibitory effect of anti-P3 Abs on cardiac CE accumulation was sufficient to reduce the collagen-filled extracellular space, the level of fibrosis, and the amount of bound water but did not counteract ECM plasticization in the heart of hypercholesterolemic rabbits.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Mechanisms modulating foam cell formation in the arterial intima, exploring new therapeutic opportunities in atherosclerosis

  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Martinez, A.
  • Claudi, Lene
  • Garcia, E.
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • Polishchuk, A.
  • Piñero, Janet|||0000-0003-1244-7654
  • Viladés Medel, David|||0000-0002-3638-9703
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Sanz, F.
  • Rotllan, Noemi|||0000-0002-0587-8045
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
In recent years, the role of macrophages as the primary cell type contributing to foam cell formation and atheroma plaque development has been widely acknowledged. However, it has been long recognized that diffuse intimal thickening (DIM), which precedes the formation of early fatty streaks in humans, primarily consists of lipid-loaded smooth muscle cells (SMCs) and their secreted proteoglycans. Recent studies have further supported the notion that SMCs constitute the majority of foam cells in advanced atherosclerotic plaques. Given that SMCs are a major component of the vascular wall, they serve as a significant source of microvesicles and exosomes, which have the potential to regulate the physiology of other vascular cells. Notably, more than half of the foam cells present in atherosclerotic lesions are of SMC origin. In this review, we describe several mechanisms underlying the formation of intimal foam-like cells in atherosclerotic plaques. Based on these mechanisms, we discuss novel therapeutic approaches that have been developed to regulate the generation of intimal foam-like cells. These innovative strategies hold promise for improving the management of atherosclerosis in the near future.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice

  • Soler Vázquez, M. Carmen|||0000-0003-1430-5617
  • Romero, María del Mar|||0000-0001-6274-5743
  • Todorcevic, Marijana
  • Delgado, Katia
  • Calatayud, Carles|||0000-0003-0032-4198
  • Benitez Amaro, Aleyda|||0000-0002-1106-3125
  • La Chica Lhoëst, María Teresa|||0000-0002-9070-5973
  • Mera, Paula|||0000-0001-8941-4637
  • Zagmutt, Sebastian|||0000-0001-6050-4452
  • Bastías Pérez, Marianela|||0000-0003-0098-8090
  • Ibeas, Kevin
  • Casals, Nuria|||0000-0002-6719-4300
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Consiglio, Antonella
  • Serra, Dolors|||0000-0002-4936-4206
  • Herrero, Laura|||0000-0003-4244-4673
Obesity and its associated metabolic comorbidities are a rising global health and social issue, with novel therapeutic approaches urgently needed. Adipose tissue plays a key role in the regulation of energy balance and adipose tissue-derived mesenchymal stem cells (AT-MSCs) have gained great interest in cell therapy. Carnitine palmitoyltransferase 1A (CPT1A) is the gatekeeper enzyme for mitochondrial fatty acid oxidation. Here, we aimed to generate adipocytes expressing a constitutively active CPT1A form (CPT1AM) that can improve the obese phenotype in mice after their implantation. AT-MSCs were differentiated into mature adipocytes, subjected to lentivirus-mediated expression of CPT1AM or the GFP control, and subcutaneously implanted into mice fed a high-fat diet (HFD). CPT1AM-implanted mice showed lower body weight, hepatic steatosis and serum insulin and cholesterol levels alongside improved glucose tolerance. HFD-induced increases in adipose tissue hypertrophy, fibrosis, inflammation, endoplasmic reticulum stress and apoptosis were reduced in CPT1AM-implanted mice. In addition, the expression of mitochondrial respiratory chain complexes was enhanced in the adipose tissue of CPT1AM-implanted mice. Our results demonstrate that implantation of CPT1AM-expressing AT-MSC-derived adipocytes into HFD-fed mice improves the obese metabolic phenotype, supporting the future clinical use of this ex vivo gene therapy approach.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile

  • Rossi-Herring, Guido|||0000-0003-1454-0916
  • Belmonte, Thalia|||0000-0003-1241-6073
  • Rivas-Urbina, Andrea|||0000-0002-0111-0477
  • Benitez, Sonia|||0000-0003-3565-0743
  • Rotllan, Noemi|||0000-0002-0587-8045
  • Crespo García, Javier|||0000-0001-8248-0172
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Gonzalo Calvo, David de|||0000-0003-2240-3532
Lipoproteins have been described as microRNAs (miRNAs) carriers. Unfortunately, the bibliography on this topic is scarce and shows a high variability between independent investigations. In addition, the miRNA profiles of the LDL and VLDL fractions have not been completely elucidated. Here, we profiled the human circulating lipoprotein-carried miRNome. Lipoprotein fractions (VLDL, LDL and HDL) were isolated from the serum of healthy subjects by ultracentrifugation and purified by size-exclusion chromatography. A panel of 179 miRNAs commonly expressed in circulation was evaluated in the lipoprotein fractions using quantitative real-time PCR (qPCR) assays. A total of 14, 4 and 24 miRNAs were stably detected in the VLDL, LDL and HDL fractions, respectively. VLDL- and HDL-miRNA signatures were highly correlated (rho 0.814), and miR-16-5p, miR-142-3p, miR-223-3p and miR-451a were among the top 5 expressed miRNAs in both fractions. miR-125a-5p, miR-335-3p and miR-1260a, were detected in all lipoprotein fractions. miR-107 and miR-221-3p were uniquely detected in the VLDL fraction. HDL showed the larger number of specifically detected miRNAs (n = 13). Enrichment in specific miRNA families and genomic clusters was observed for HDL-miRNAs. Two sequence motifs were also detected for this group of miRNAs. Functional enrichment analysis including the miRNA signatures from each lipoprotein fraction suggested a potential role in mechanistic pathways previously associated with cardiovascular disease: fibrosis, senescence, inflammation, immune response, angiogenesis, and cardiomyopathy. Collectively, our results not only support the role of lipoproteins as circulating miRNA carriers but also describe for the first time the role of VLDL as a miRNA transporter.